Oxidized high-density lipoprotein induces the proliferation and migration of vascular smooth muscle cells by promoting the production of ROS

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 3, 2014, Pages 204-216

  Wang, Yan ^a,b   Ji, Liang ^c   Jiang, Rengui ^a,b   Zheng, Lemin ^c   Liu, Donghui ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Migration; Ox HDL; Proliferation; ROS; VSMCs

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ACETYLCYSTEINE; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID OXIDATION; MALE; NONHUMAN; RAT; RISK FACTOR; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; LIPOPROTEINS, HDL; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84897043160     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.19448     Document Type: Article

References (43)

1. Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126
2. Lowe HC, Oesterle SN, Khachigian LM: Coronary instent restenosis: current status and future strategies. J Am Coll Cardiol, 2002; 39: 183-193
3. Rudijanto A: The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones, 2007; 39: 86-93
4. Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H: ROS and PDFG-bera receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol, 2009; 297: C389-396
5. Wedgwood S, Dettman RW, Black SM: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol, 2001; 281: L1058-1067
6. Yaghini FA, Song CY, Lavrentyev EN, Ghafoor HUB, Fang XR, Estes AM, Campbell WB, Malik KU: Angiotensin II-induced Vascular Smooth Muscle Cell Migration and Growth Are Mediated by Cytochrome P450 1B1-dependent Superoxide Generation. Hypertension, 2010; 55: 1461-1467
7. Robbesyn F, Garcia V, Auge N, Vieira O, Frisach M-F, Salvayre R, Negre-Salvayre A: HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J, 2003; 17: 743-745
8. Gotto AMJ, Brinton EA: Assessing low levels of highdensity lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol, 2004; 43: 717-724
9. Assmann G, Nofer JR: Atheroprotective effects of highdensity lipoproteins. Annu Rev Med, 2003; 54: 321-341
10. Brewer HB: High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease. Arterioscler Thromb Vasc Biol, 2004; 24: 387-391
11. Calabresi L, Gomaraschi M, Franceschini G: Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol, 2003; 23: 1724-1731
12. Mineo C, Shaul PW: Novel Biological Functions of High-Density Lipoprotein Cholesterol, Circ Res. 2012; 111: 1079-1090
13. Tamama K, Tomura H, Sato K, Malchinkhuu E, Damirin A, Kimura T, Kuwabara A, Murakami M, Okajima F: High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis, 2005; 178: 19-23
14. Sun L, Ishida T, Okada T, Yasuda T, Hara T, Toh R, Shinohara M, Yamashita T, Rikitake Y, Hirata K-i: Expression of Endothelial Lipase Correlates with the Size of Neointima in a Murine Model of Vascular Remodeling. J Atheroscler Thromb, 2012; 19: 1110-1127
15. Ansell BJ, Fonarow GC, Fogelman AM: High-density lipoprotein: is it always atheroprotective? Curr Athero scler Rep, 2006; 8: 405-411
16. Ansell BJ, Fonarow GC, Fogelman AM: The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol, 2007; 18: 427-434
17. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM: Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment. Circulation, 2003; 108: 2751-2756
18. Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, Davidson M, Rysz J, Banach M: Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res, 2012; 51: 314-324
19. Kontush A, Chapman MJ: Functionally defective highdensity lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev, 2006; 58: 342-374
20. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest, 2004; 114: 529-541
21. Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL: Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem, 2009; 284: 30825-30835
22. Nagano Y, Arai H, Kita T: High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci U S A, 1991; 88: 6457-6461
23. Rifici VA, Khachadurian AK: Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim Biophys Acta, 1996; 1299: 87-94
24. Matsunaga T, Hokari S, Koyama I, Harada T, Komoda T: NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochem Biophys Res Commun, 2003; 303: 313-319
25. Soumyarani VS, Jayakumari N: Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-alpha, MMP-9, and MMP-2. Mol Cell Biochem, 2012; 366: 277-285
26. Callegari E, Norata GD, Inoue H, Catapano AL: Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells. Int J Mol Med, 2006; 18: 209-213
27. Norata GD, Banfi C, Pirillo A, Tremoli E, Hamsten A, Catapano AL, Eriksson P: Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization. Br J Haematol, 2004; 127: 97-104
28. Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, Pan L, Li J, Yang L, Lv X, Shen X, Chen B, Zhang Y, Willard B, He Y, Zheng L: High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer, 2012; 131: 70-82
29. Pan B, Ren H, Lv X, Zhao Y, Yu B, He Y, Ma Y, Niu C, Kong J, Yu F, Sun W-b, Zhang Y, Willard B, Zheng L: Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis. J Transl Med, 2012; 10: 1-13
30. Pan B, Yu B, Ren H, Willard B, Pan L, Zu L, Shen X, Ma Y, Li X, Niu C, Kong J, Kang S, Chen E, Pennathur S, Zheng L: High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair. Free Radic Biol Med, 2013; 60: 272-281. doi: 210.1016/j.freeradbiomed.2013.1002. 1004
31. Liu D, Ji L, Tong X, Pan B, Han J-Y, Huang Y, Chen YE, Pennathur S, Zhang Y, Zheng L. Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1. Am J Physiol Cell Physiol. 2011; 301: C739-748
32. Nakajima T, Origuchi N, Matsunaga T, Kawai S-i, Hokari S, Nakamura H, Inoue I, Katayama S, Nagata A, Komoda T: Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem, 2000; 37: 179-186
33. Lyle AN, Griendling KK: Modulation of Vascular Smooth Muscle Signaling by Reactive Oxygen Species. Physiology, 2006; 21: 269-280
34. Clempus RE, Griendling KK: Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res, 2006; 71: 216-225
35. Niu X-L, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause K-H, Humphries J, Smith A, Burnand KG, Runge MS: Nox Activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation, 2010; 121: 549-559
36. Wang J, Shi N, Chen S-Y: Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells. Free Radic Biol Med, 2012; 52: 173-181
37. Nuria M, Nuria L, Verónica A, Daniel M, Antonio C, Julián N, Leocadio R-M, Carlos F S-F, Concepción P: Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. J Hypertens, 2007; 25: 609-618
38. Satoh K, Nigro P, Berk BC: Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal, 2010; 12: 675-682
39. Tolle M, Pawlak A, Schuchardt M, Kawamura A, Tietge UJ, Lorkowski S, Keul P, Assmann G, Chun J, Levkau B, van der Giet M, Nofer J-R: HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production. Arterioscler Thromb Vasc Biol, 2008; 28: 1542-1548
40. Thorne RF, Mhaidat NM, Ralston KJ, Burns GF: CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett, 2007; 581: 1227-1232
41. Li W, Febbraio M, Reddy SP, Yu D-Y, Yamamoto M, Silverstein RL: CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest, 2010; 120: 3996-4006
42. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y: AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation, 2004; 110: 444-451
43. Mahadevan VS, Campbell M, McKeown PP, Bayraktutan U: Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc Res, 2006; 72: 60-68